Peru inks deal with Sinopharm for COVID vaccines
2021-01-07 15:48
A signage of Sinopharm is seen at the  China International Fair for Trade in Services CIFTIS, following the COVID outbreak, in Beijing, Sept , . PhotoAgencies    LIMA  Peru has signed an agreement with Chinese pharmaceutical firm Sinopharm to acquire its vaccine against COVID, with the first  million doses to arrive this month, Peruvian President Francisco Sagasti announced Wednesday. In a nationwide address, Sagasti said Perus cooperation in Sinopharm phase  trials placed the country in a better position to access vaccines and to verify their effectiveness in the national population. Clinical trials of the Sinopharm vaccine are currently underway at the Cayetano Heredia Peruvian University and the National University of San Marcos. According to Perus National Institute of Health, which is overseeing the process, , volunteers have been vaccinated since the trials began in September. Peru has registered more than  million COVID cases and over , deaths.